Indium-105: Clinical Trials

2 trials of Indium-105, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2

Follow Indium-105: new trials by email Literature Review of Indium-105 trials Research Report on Indium-105

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
Tregopil - Type 1 Diabetes Mellitus (T1DM)
Phase 1TerminatedBiocon Limited552019-10-282022-06-27
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
IN-105, Insulin Lispro Injection - Type 1 Diabetes Mellitus
Phase 1TerminatedBiocon Limited202010-08-212018-01-23

Conditions studied

Diabetes Mellitus, Type 1 (2)

Sponsors

Biocon Limited (2)

Countries

Germany (1)  ·  India (1)

Top investigators

Dr Bipin Kumar Sethi, MD, DM (1)  ·  Dr. Aravind R Sosale, DNB (1)  ·  Dr. K.M. Prasanna Kumar, MD, DM (1)  ·  Dr. Neeta Deshpande, MD (1)  ·  Dr. Sanjay Kalra, MD, DM (1)

Results publications

PMID 40211481